NeoGenomics
NEO • NASDAQ
NeoGenomics is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Anthony Zook, with a market cap of $933.3M.
CEOAnthony Zook
Next Earnings
Upcoming earnings announcement for NeoGenomics
Date
Tuesday, April 28, 2026 (in 3 weeks)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.03
Revenue Estimate
$184.5M
Earnings History
Past 12 earnings reports for NeoGenomics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | Q4 2025 | $0.06Est: $0.01 | +500.0% | $190.2MEst: $188.4M | +1.0% |  10-K |
| Oct 28, 2025 | Q3 2025 | $0.03Est: -$0.01 | +400.0% | $187.8MEst: $183.8M | +2.2% | — |
| Jul 29, 2025 | Q2 2025 | $0.03Est: -$0.01 | +400.0% | $181.3MEst: $182.8M | -0.8% | 10-Q |
| Apr 29, 2025 | Q1 2025 | $0.00Est: -$0.01 | +100.0% | $168.0MEst: $170.9M | -1.7% | 10-Q |
| Feb 18, 2025 | Q4 2024 | $0.04Est: $0.03 | +33.3% | $172.0MEst: $173.4M | -0.8% | 10-K |
| Nov 5, 2024 | Q3 2024 | $0.05Est: $0.01 | +400.0% | $167.8MEst: $167.0M | +0.5% | 10-Q |
| Jul 29, 2024 | Q2 2024 | $0.03Est: $0.00 | — | $164.5MEst: $161.9M | +1.6% | 10-Q |
| Apr 30, 2024 | Q1 2024 | -$0.02Est: -$0.05 | +60.0% | $156.2MEst: $149.9M | +4.2% | 10-Q |
| Feb 20, 2024 | Q4 2023 | $0.03Est: -$0.02 | +250.0% | $155.6MEst: $152.5M | +2.0% | 10-K |
| Nov 6, 2023 | Q3 2023 | $0.00Est: -$0.08 | +100.0% | $152.0MEst: $142.0M | +7.0% | — |
| Aug 8, 2023 | Q2 2023 | -$0.05Est: -$0.11 | +54.5% | $146.9MEst: $137.4M | +6.9% | 10-Q |
| May 8, 2023 | Q1 2023 | -$0.09Est: -$0.15 | +40.0% | $137.2MEst: $126.4M | +8.6% | 10-Q |